DUSA Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- DUSA Pharmaceuticals's estimated annual revenue is currently $43M per year.
- DUSA Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- DUSA Pharmaceuticals has 214 Employees.
DUSA Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|
DUSA Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $413.3M | 340 | 0% | $634M | N/A |
#2 | $57.9M | 288 | 0% | N/A | N/A |
#3 | $2M | 10 | -17% | N/A | N/A |
#4 | $33.6M | 167 | 20% | N/A | N/A |
#5 | $15.5M | 77 | 126% | N/A | N/A |
#6 | $25.1M | 125 | 8% | $113M | N/A |
#7 | $0.3M | 3 | 0% | N/A | N/A |
#8 | $10.1M | 50 | -2% | N/A | N/A |
#9 | $1.8M | 385 | -4% | $538M | N/A |
#10 | $46.6M | 232 | -7% | N/A | N/A |
What Is DUSA Pharmaceuticals?
Development Associates, a proprietorship formed in 1985 which provides consulting and venture support services to manage and finance early-stage technology-based companies DUSA Pharmaceuticals, Inc.® is a fully integrated specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® Kerastick® (aminolevulinic acid HCl) for Topical Solution, 20% photodynamic therapy (PDT) technology platform used in conjunction with it’s proprietary light source, the BLU-U® Blue Light Photodynamic Therapy Illuminator. LEVULAN KERASTICK in combination with the BLU-U is approved by the U.S. Food and Drug Administration for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp
keywords:N/A
N/A
Total Funding
214
Number of Employees
$43M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
DUSA Pharmaceuticals News
Dusa Pharmaceuticals; Novartis; Perrigo; Leo Pharma; Bausch Health; Taro Pharmaceutical; Galderma (nestle); Biofrontera; Almirall; Tolmar Pharmaceutical.
... Inc., LEO Pharma A/S, Mylan N.V., Novartis AG, Stanford Chemicals, and Sun Pharmaceutical Industries Ltd. (DUSA Pharmaceuticals, Inc.).
Other Companies in Wilmington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $30.1M | 215 | 6% | N/A |
#2 | $49.9M | 216 | 0% | N/A |
#3 | $64.4M | 217 | 10% | N/A |
#4 | $59.7M | 217 | 23% | N/A |
#5 | $24.5M | 218 | -3% | N/A |